Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Shares Issued (2021 - 2025)

Janux Therapeutics (JANX) has disclosed Shares Issued for 4 consecutive years, with $901000.0 as the latest value for Q1 2025.

  • Quarterly Shares Issued fell 45.62% to $901000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Mar 2025, up 27.83% year-over-year, with the annual reading at $204.2 million for FY2021, N/A changed from the prior year.
  • Shares Issued for Q1 2025 was $901000.0 at Janux Therapeutics, down from $1.7 million in the prior quarter.
  • The five-year high for Shares Issued was $1.7 million in Q1 2024, with the low at -$843000.0 in Q3 2021.
  • Average Shares Issued over 4 years is $823750.0, with a median of $1.2 million recorded in 2023.
  • The sharpest move saw Shares Issued increased 4.87% in 2024, then tumbled 45.62% in 2025.
  • Over 4 years, Shares Issued stood at -$843000.0 in 2021, then surged by 287.43% to $1.6 million in 2023, then grew by 4.87% to $1.7 million in 2024, then crashed by 45.62% to $901000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $901000.0, $1.7 million, and $1.6 million for Q1 2025, Q1 2024, and Q1 2023 respectively.